J&J (JNJ) is up a tick to $61.16 and should open higher on news that it had prevailed in a patent dispute with Boston Scientific (BSX). The value of the settlement involving 16 stent patents is $716 million. Douglas A. McIntyre
Johnson & Johnson news and information regarding our operations, products, leaders, and our charitable giving.
DJIA Component Earnings on Deck (AA, INTC, JNJ, JPM, IBM, BAC, GE
Posted by jw | 10:14 PM | 0 comments »
Subscribe to:
Post Comments (Atom)
0 comments
Post a Comment